Brain edema Early brain injury Microglia Netrin-1 Neuroinflammation Subarachnoid hemorrhage a b s t r a c t Neuroinflammation is an essential mechanism involved in the pathogenesis of subarachnoid hemorrhage (SAH)-induced brain injury. Recently, Netrin-1 (NTN-1) is well established to exert anti-inflammatory property in non-nervous system diseases through inhibiting infiltration of neutrophil. The present study was designed to investigate the effects of NTN-1 on neuroinflammation, and the potential mechanism in a rat model of SAH. Two hundred and ninety-four male Sprague Dawley rats (weight 280-330 g) were subjected to the endovascular perforation model of SAH. Recombinant human NTN-1 (rh-NTN-1) was administered intravenously. Small interfering RNA (siRNA) of NTN-1 and UNC5B, and a selective PPARc antagonist bisphenol A diglycidyl ether (BADGE) were applied. Post-SAH evaluations included neurobehavioral function, brain water content, Western blot analysis, and immunohistochemistry. Our results showed that endogenous NTN-1 and its receptor UNC5B level were increased after SAH. Administration of rh-NTN-1 reduced brain edema, ameliorated neurological impairments, and suppressed microglia activation after SAH, which were concomitant with PPARc activation, inhibition of NFjB, and decrease in TNF-a, IL-6, and ICAM-1, as well as myeloperoxidase (MPO). Knockdown of endogenous NTN-1 increased expression of pro-inflammatory mediators and MPO, and aggravated neuroinflammation and brain edema. Moreover, knockdown of UNC5B using specific siRNA and inhibition of PPARc with BADGE blocked the protective effects of rh-NTN-1. In conclusion, our findings indicated that exogenous rh-NTN-1 treatment attenuated neuroinflammation and neurological impairments through inhibiting microglia activation after SAH in rats, which is possibly mediated by UNC5B/PPARc/NFjB signaling pathway. Exogenous NTN-1 may be a novel therapeutic agent to ameliorating early brain injury via its anti-inflammation effect.
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Introduction
Activation of neuroinflammatory response plays a crucial role in the progression and exacerbation of brain injury following subarachnoid hemorrhage (SAH) (Lucke-Wold et al., 2016) . The innate immune response triggered by SAH is characterized by leukocyte infiltration, resident immune cells activation, and release of proinflammatory mediators within brain tissues, which result in blood-brain barrier (BBB) disruption and brain injury via various mechanisms (Frontera et al., 2012; Frontera et al., 2017) . Therefore, inhibition of inflammatory response represent a potential treatment for attenuating brain injury following SAH (Chen et al., 2014; Provencio et al., 2016) .
Netrin-1 (NTN-1), a laminin-related molecule, was initially discovered as a chemoattractive or chemorepulsive cue for directing axon outgrowth and neuron migrating during the development of the nervous system (Serafini et al., 1996) . NTN-1 is also known to modulate the immune response via the inhibition of inflammatory cells migration and control inflammation in non-nervous https://doi.org/10.1016/j.bbi.2017.11.012 0889-1591/Ó 2017 Elsevier Inc. All rights reserved.
